• Something wrong with this record ?

The role of biomembranes in chromium (III)-induced toxicity in vitro

Rudolf E., Červinka M.

. 2005 ; 33 (3) : 249-259.

Language English Country Great Britain

The role of biomembranes in the chronic toxicity of environmentally occurring chromium acetate hydroxide was investigated by using primary human fibroblasts. Transport of chromium acetate hydroxide across the plasma membrane of the cell, and the effects of chromium (III) ions on the plasma membrane as well as other intracellular membranes, were determined during six weeks of continuous exposure by using atomic absorption spectrometry, observation of cell morphology, membrane integrity assays (for lactate dehydrogenase leakage and lysosomal membrane disruption), and mitochondrial assays (for mitochondrial dehydrogenase activity and mitochondrial transmembrane potential analysis). The type of cell death induced by long-term exposure was determined in terms of phosphatidylserine externalisation, caspase-3 activation, and chromatin fragmentation. Chromium acetate hydroxide, at a concentration of 100 micromol/l, accumulated in exposed cells, inflicting plasma membrane damage and suppressing mitochondrial function. Antioxidant co-enzyme Q, at a concentration of 10 micromol/l, partially prevented plasma membrane damage and mitochondrial dysfunction. Exposure to chromium acetate hydroxide produced apoptosis, necrosis and an intermediate type of cell death in primary human fibroblasts. These results show that the plasma membrane and mitochondrial membrane are important targets for chronic chromium acetate hydroxide toxicity, and that this in vitro system holds promise for studying the toxicity resulting from long-term exposure to metal ions.

000      
03668naa 2200457 a 4500
001      
bmc07500439
003      
CZ-PrNML
005      
20120604114200.0
008      
070711s2005 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rudolf, Emil, $d 1970- $7 xx0076300
245    14
$a The role of biomembranes in chromium (III)-induced toxicity in vitro / $c Rudolf E., Červinka M.
314    __
$a Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. rudolf@lfhk.cuni.cz
520    9_
$a The role of biomembranes in the chronic toxicity of environmentally occurring chromium acetate hydroxide was investigated by using primary human fibroblasts. Transport of chromium acetate hydroxide across the plasma membrane of the cell, and the effects of chromium (III) ions on the plasma membrane as well as other intracellular membranes, were determined during six weeks of continuous exposure by using atomic absorption spectrometry, observation of cell morphology, membrane integrity assays (for lactate dehydrogenase leakage and lysosomal membrane disruption), and mitochondrial assays (for mitochondrial dehydrogenase activity and mitochondrial transmembrane potential analysis). The type of cell death induced by long-term exposure was determined in terms of phosphatidylserine externalisation, caspase-3 activation, and chromatin fragmentation. Chromium acetate hydroxide, at a concentration of 100 micromol/l, accumulated in exposed cells, inflicting plasma membrane damage and suppressing mitochondrial function. Antioxidant co-enzyme Q, at a concentration of 10 micromol/l, partially prevented plasma membrane damage and mitochondrial dysfunction. Exposure to chromium acetate hydroxide produced apoptosis, necrosis and an intermediate type of cell death in primary human fibroblasts. These results show that the plasma membrane and mitochondrial membrane are important targets for chronic chromium acetate hydroxide toxicity, and that this in vitro system holds promise for studying the toxicity resulting from long-term exposure to metal ions.
650    _2
$a sloučeniny chromu $x toxicita $7 D017608
650    _2
$a látky znečišťující životní prostředí $x toxicita $7 D004785
650    _2
$a intracelulární membrány $x enzymologie $x účinky léků $7 D007425
650    _2
$a mitochondrie $x enzymologie $x účinky léků $7 D008928
650    _2
$a organokovové sloučeniny $x toxicita $7 D009942
650    _2
$a apoptóza $x účinky záření $7 D017209
650    _2
$a kultivované buňky $7 D002478
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a fibroblasty $x metabolismus $x patologie $x účinky léků $7 D005347
650    _2
$a L-laktátdehydrogenasa $x metabolismus $7 D007770
650    _2
$a nekróza $7 D009336
650    _2
$a kůže $x metabolismus $x patologie $x účinky léků $7 D012867
650    _2
$a ubichinon $x farmakologie $7 D014451
650    _2
$a lidé $7 D006801
650    _2
$a financování vládou $7 D005380
700    1_
$a Červinka, Miroslav, $d 1950- $7 nlk19990074194
773    0_
$w MED00000610 $t ATLA $g Roč. 33, č. 3 (2005), s. 249-259 $x 0261-1929
910    __
$a ABA008 $b x $y 1
990    __
$a 20070711125742 $b ABA008
991    __
$a 20120604114127 $b ABA008
999    __
$a ok $b bmc $g 616053 $s 468485
BAS    __
$a 3
BMC    __
$a 2005 $b 33 $c 3 $d 249-259 $i 0261-1929 $m ATLA. Alternatives to laboratory animals $x MED00000610
LZP    __
$a 2007-2/jtjt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...